Toyokazu Miki

Title: Toyokazu Miki: Innovator in Bone Metastasis Research

Introduction

Toyokazu Miki is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of cancer research, particularly in understanding bone metastasis. With a total of 2 patents, Miki's work focuses on developing innovative models for studying tumor behavior and potential therapeutic strategies.

Latest Patents

Miki's latest patents include groundbreaking inventions aimed at advancing cancer research. The first patent, titled "Non-human animal exhibiting bone metastasis of tumor cells," presents a non-human bone metastasis model animal. This model allows for the introduction of tumor cells capable of inducing bone metastasis through peripheral administration. It serves as a valuable tool for understanding the biology of bone metastasis and developing novel therapeutic strategies for lung cancer patients with multi-organ metastases, including bone metastasis.

The second patent, "Non-human animal exhibiting bone metastasis of tumor cells and method of screening for bone metastasis inhibitors," builds upon the first. It also provides a non-human bone metastasis model animal and introduces a method for screening agents that inhibit or prevent bone metastasis of tumor cells. This invention further enhances the understanding of bone metastasis and aids in the search for effective treatments.

Career Highlights

Toyokazu Miki is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to collaborate with other experts in the field and contribute to significant advancements in cancer research.

Collaborations

Miki has worked alongside his coworker, Saburo Sone, to further enhance the research and development of innovative cancer therapies. Their collaboration has been instrumental in pushing the boundaries of current understanding in the field.

Conclusion

Toyokazu Miki's contributions to cancer research, particularly in the area of bone metastasis, highlight his role as an influential inventor. His innovative patents provide valuable resources for understanding and combating cancer, ultimately aiming to improve patient outcomes.